Deerfield Beach, FL -- (SBWIRE) -- 07/14/2015 -- Although pediatrics represent around two-fifths of the global population the market for pediatric medicines remains relatively small (accounting for <10% of global pharmaceutical sales). Until pediatric legislation was introduced in the US (1997) and EU (2007) there has been little incentive for the pharma industry to evaluate drugs in children due to the low medical need of chronic illnesses and the high off-label use of generic drugs (Milne & Bruss, 2008).

Since the introduction of pediatric legislation there has been a substantial investment in pediatric research and the number of clinical trials performed in children has increased significantly. In the US more than 350 product labels include new pediatric information and more than 130 products have undergone a pediatric focused post-labelling safety review. In Europe there has been 221 changes regarding the safety and efficacy of medicines from the submission of old or new studies in children and 89 additions of dosing information for children as a direct consequence of Paediatric Investigation Plans (PIPs).

Request Sample Report:
http://www.marketresearchstore.com/report/pediatric-drug-development-regulatory-challenges-and-commercial-19600#requestSample

Despite the apparent success of the pediatric regulation, the submission of pediatric information is complex and the incentives are often insufficient to encourage industry innovation (Rose & Della Pasqua, 2011). No new drugs can be registered in the EU without a detailed PIP being approved by the EMA's Pediatric Committee (PDCO) (Rose, 2014). Without a PIP, the registration process for a new drug can be blocked. In the US, the FDA has adopted a more pragmatic approach to pediatric drug development, providing voluntary and mandatory routes for pediatric evaluation.

Many experts agree that there is significant room to improve the EU pediatric regulations and a revision of the legislation is scheduled to take place in 2018. In the meantime, there is considerable potential for the industry to develop pediatric formulations and doses of approved and generic medicines, particularly for use in transition countries where access to high quality pediatric formulation is improving. In addition, new commercial opportunities exist to develop medicines that target pediatric specific conditions in neonates as well as rare and neglected diseases and pediatric vaccines.

Browse the full report of Pediatric Drug Development Market:
http://www.marketresearchstore.com/report/pediatric-drug-development-regulatory-challenges-and-commercial-19600

Scope

Pediatric medicines: an overview
The pediatric population
Underlying/key issues for pediatric drug development
Unmet clinical needs
Current landscape
Regulation and legislation
Global harmonization
Strategic considerations for developing pediatric medicines
Clinical trial considerations
Pediatric formulation issues
Pediatric networks
Patient access
Commercial opportunities
Generic formulations and dosage forms
Rare and neglected diseases
Pediatric vaccines

Browse the full report of Pediatric Drug Development Market:
http://www.marketresearchstore.com/report/pediatric-drug-development-regulatory-challenges-and-commercial-19600

Key Reasons to Purchase

Reviews the current regulatory landscape and helps sponsors to understand the potential impact of FDA SIA regulations and the variations between EU regulation on global pediatric plans;

Identifies the key challenges associated with pediatric drug development and the ways to overcome these hurdles;

Assesses what issues need to be addressed in order to improve access to pediatric medicines and commercial opportunities in transition countries based on KOL insights;

Analyses different strategies to develop age-appropriate medicines in niche therapeutic fields in neonates, rare and neglected pediatric diseases and pediatric vaccines.

About Market Research Store
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:
3422 SW 15 Street,
Suit #8138,
Deerfield Beach,
Florida 33442,
USA Tel: 386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651